Proteomic analyses of urinary exosomes identify novel potential biomarkers for early diagnosis of sickle cell nephropathy, a sex-based study.

albuminuria cathepsin C chronic kidney disease gender difference heparanase sarcoplasmic endoplasmic Ca2+ ATPase-3 sex difference α2-macroglobulin

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2024
Historique:
received: 23 09 2023
accepted: 26 01 2024
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: epublish

Résumé

Sickle cell nephropathy (SCN) is a leading cause of morbidity and mortality in sickle cell disease (SCD). Early intervention is crucial for mitigating its effects. However, current diagnostic methods rely on generic tests and may not detect SCN until irreversible renal damage occurs. Therefore, specific biomarkers for early diagnosis of SCN are needed. Urinary exosomes, membrane-bound vesicles secreted by renal podocytes and epithelial cells, contain both common and cell type-specific membrane and cytosolic proteins, reflecting the physiologic and pathophysiologic states of the kidney. Using proteomics, we analyzed the proteomes of urinary exosomes from humanized SCD mice at 2 months (without albuminuria) and 4 months (with albuminuria) of age. Excretion of 164 proteins were significantly increased and 176 proteins was significantly decreased in the exosomes when mice developed albuminuria. Based on the relevance to SCD, chronic kidney disease and Western blot confirmation in mice, we analyzed protein abundance of heparanase, cathepsin C, α2-macroglobulin and sarcoplasmic endoplasmic Ca

Identifiants

pubmed: 38426210
doi: 10.3389/fphys.2024.1300667
pii: 1300667
pmc: PMC10901968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1300667

Informations de copyright

Copyright © 2024 Packialakshmi, Limerick, Ackerman, Lin, Nekhai, Oliver, Stewart, Knepper, Fitzhugh and Zhou.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Balamurugan Packialakshmi (B)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, United States.

Emily Limerick (E)

Cellular and Molecular Therapeutic Branch, National Heart Lung and Blood Institute, Bethesda, MD, United States.

Hans C Ackerman (HC)

Physiology Unit, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, United States.

Xionghao Lin (X)

Department of Medicine, Howard University, Washington, DC, United States.

Sergei Nekhai (S)

Department of Medicine, Howard University, Washington, DC, United States.

James D Oliver (JD)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, United States.
Nephrology Service, Walter Reed National Military Medical Center, Bethesda, MD, United States.

Ian J Stewart (IJ)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, United States.

Mark A Knepper (MA)

System Biology Center, National Heart Lung and Blood Institute, Bethesda, MD, United States.

Courtney Fitzhugh (C)

Cellular and Molecular Therapeutic Branch, National Heart Lung and Blood Institute, Bethesda, MD, United States.

Xiaoming Zhou (X)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD, United States.

Classifications MeSH